Lactobacillus plantarum with function of relieving hyperoxaluria and application of lactobacillus plantarum in vegetable fermentation
Fermenting vegetables with Lactobacillus plantarum AR1089 solves the problems of treating and preventing hyperoxaluria, reduces urinary oxalate content, improves kidney function, reduces calcium oxalate deposition in the kidneys, and enhances the flavor of vegetables.
Patent Information
- Application Number
- CN202411078159.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-07
- Publication Date
- 2024-11-08
AI Technical Summary
Existing technologies are insufficient to effectively alleviate hyperoxaluria, which leads to kidney stones and kidney disease. Furthermore, the high oxalate content in vegetables such as spinach affects both taste and health.
Vegetables fermented with Lactobacillus plantarum AR1089 are used to reduce the oxalic acid content in vegetables and to treat and prevent hyperoxaluria by reducing renal oxidative stress and gene expression.
It effectively reduces urinary oxalate levels, improves kidney function, reduces calcium oxalate deposition in the kidneys, alleviates kidney damage, enhances probiotic flavor, and is suitable for a wider range of people.
Smart Images

Figure CN118909858A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of biotechnology, in particular to a plant lactobacillus strain capable of alleviating hyperoxaluria and application thereof in vegetable fermentation. Background Art
[0002] When oxalate metabolism in the human body is disordered, urinary oxalate excretion increases. When it exceeds 45 mg / d, it can be defined as hyperoxaluria, which is an important predisposing factor for kidney stones. Hyperoxaluria is an important risk factor for the occurrence of kidney stones. Therefore, the prevention of hyperoxaluria is particularly important. Excessive exogenous intake of oxalate and excessive endogenous synthesis are the main causes of hyperoxaluria, which can further lead to a series of kidney diseases, such as systemic oxalic acid storage disease, nephrocalcinosis, renal failure, and especially calcium oxalate (CaOx) stones. Oxalate is the terminal metabolite of the human liver, usually derived from the diet, and eventually precipitated as CaOx crystals in the kidneys. Calcium oxalate stones are the main component of kidney stones, accounting for more than 80%. Studies have shown that intestinal hyperoxaluria and calcium oxalate stones are common complications in patients with inflammatory bowel disease. Intake of oxalate may cause severe kidney stones and even cause severe toxicity to the gastrointestinal tract (GIT) and induce intestinal dysfunction, including diarrhea, intestinal inflammation, gastric bleeding, and GIT epithelial cell degeneration. The defective permeability barrier caused by mucosal inflammation, dysfunction and diarrhea will promote the enhanced absorption of oxalate, thus creating a vicious cycle. Therefore, it is urgent to find effective ways to alleviate kidney damage and reduce gastrointestinal oxalate. The human body needs to rely on intestinal microorganisms to maintain oxalate homeostasis and maintain oxalate absorption and secretion by regulating oxalate homeostasis.
[0003] Vegetarianism is a growing trend in modern lifestyle. The change of consumer preferences is a dynamic process. Consumers' health awareness is gradually increasing, and they are more and more concerned about the beneficial value of food. Therefore, the development of functional foods should also be taken seriously. For decades, the probiotics market has been mainly concentrated on dairy products. However, the increase in vegetarianism and hypercholesterolemia has forced probiotic products to develop into a wider field. Vegetable matrix is considered to be a potential probiotic carrier. With the development of various probiotic products, probiotic fermented beverages may be a new antioxidant and anti-fatigue product. Probiotic lychee juice can alleviate immune dysfunction in mice and change the structure of intestinal flora, providing a potential functional food for improving host health. Spinach has the effects of detoxification, blood circulation and gastrointestinal stimuli. Spinach is also rich in carotenoids, vitamin C, vitamin K and other trace elements. However, spinach contains a lot of oxalic acid, which not only affects the taste of spinach, but also increases the risk of kidney stones and osteoporosis. It is not suitable for patients with kidney stones. Therefore, the present invention provides a method for fermenting vegetables using probiotics, which can not only reduce the oxalic acid content in the vegetables and alleviate the astringency, but also increase the unique flavor of the probiotics, making the vegetables suitable for consumption by more people. Summary of the invention
[0004] The purpose of the present invention is to provide a strain of Lactobacillus plantarum with the function of relieving hyperoxaluria and its application in vegetable fermentation to solve the problems existing in the above-mentioned prior art. The Lactobacillus plantarum AR1089 provided by the present invention can effectively reduce the urine oxalic acid content and relieve hyperoxaluria. It can also be applied to fermented vegetables to reduce the oxalic acid content in vegetables.
[0005] To achieve the above object, the present invention provides the following solutions:
[0006] The invention provides a strain of Lactobacillus plantarum AR1089, wherein the preservation number of the Lactobacillus plantarum AR1089 is CGMCC No.27369, the preservation date is May 17, 2023, the preservation unit is the General Microbiology Center of China National Committee for the Preservation of Microorganisms, and the preservation address is No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing.
[0007] The present invention also provides the use of the Lactobacillus plantarum AR1089 in preparing a medicine for treating and / or preventing hyperoxaluria.
[0008] Furthermore, the Lactobacillus plantarum AR1089 plays a role in treating and / or preventing hyperoxaluria by reducing kidney oxidative stress response or reducing the expression level of OPN, KIM-1 or MCP-1 genes.
[0009] The invention also provides a vegetable fermentation agent, comprising the Lactobacillus plantarum AR1089.
[0010] The present invention also provides application of the Lactobacillus plantarum AR1089 or the vegetable fermentation agent in reducing the oxalic acid content in vegetables.
[0011] Furthermore, the Lactobacillus plantarum AR1089 is inoculated into vegetables in the form of a strain or a bacterial liquid for fermentation to reduce the oxalic acid content in the vegetables.
[0012] Furthermore, in terms of volume percentage, the inoculation amount of the Lactobacillus plantarum AR1089 is 1%-10%.
[0013] Furthermore, in terms of volume percentage, the inoculation amount of the Lactobacillus plantarum AR1089 is 5%.
[0014] Furthermore, the vegetables include spinach or bamboo shoots.
[0015] The present invention also provides application of the Lactobacillus plantarum AR1089 or the vegetable fermentation agent in preparing vegetable fermented food, wherein the vegetables include spinach or bamboo shoots.
[0016] The present invention discloses the following technical effects:
[0017] The Lactobacillus plantarum AR1089 provided by the present invention belongs to the genus Lactobacillus and the species Lactobacillus plantarum through 16SrDNA identification, and is listed in the "List of Bacteria that Can Be Used in Food", indicating that the strain is safe to eat. Experimental verification shows that Lactobacillus plantarum AR1089 can improve renal function damage by reducing kidney oxidative stress response or reducing the expression of OPN, KIM-1 or MCP-1 genes, and play a role in treating or preventing hyperoxaluria.
[0018] By fermenting vegetables with the plant lactobacillus AR1089 provided by the present invention, the oxalic acid content can be reduced, the astringency can be alleviated, and the unique flavor of probiotics can be increased, making the vegetables suitable for consumption by more people. The present invention provides an effective, safe and reliable new approach for preventing or treating diseases caused by high oxalic acid. BRIEF DESCRIPTION OF THE DRAWINGS
[0019] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0020] Figure 1Effects of AR1089 on serum indexes of rats with hyperoxaluria; A: creatinine content; B: urea nitrogen content; C: MDA content; *** indicates P < 0.001, **** indicates P < 0.0001;
[0021] Figure 2 Effects of AR1089 on the antioxidant capacity of kidney in rats with hyperoxaluria; A: kidney coefficient; B: SOD enzyme activity; C: CAT enzyme activity; ** indicates P < 0.01, **** indicates P < 0.0001;
[0022] Figure 3 The effect of AR1089 on urine oxalic acid content in rats with hyperoxaluria; * indicates P < 0.05, *** indicates P < 0.001;
[0023] Figure 4 The left figure is the staining analysis of kidney pathology in rats with hyperoxaluria. A: HE staining; B: Masson staining; C: Pizzolato staining; D: Quantitative analysis of Masson staining; E: Calcium crystal score; * indicates P < 0.05, **** indicates P < 0.0001; the scale bar is 100 μm.
[0024] Figure 5 Figure 2 shows the alleviating effect of AR1089 on renal injury in rats with hyperoxaluria; A shows the relative expression levels of OPN, KIM-1 and MCP-1 genes; B shows the immunohistochemical staining analysis of OPN and MCP-1, where the left picture is the staining picture and the right picture is the quantitative analysis; * indicates P < 0.05, ** indicates P < 0.01, *** indicates P < 0.001, and the scale bar is 100 μm. DETAILED DESCRIPTION
[0025] Various exemplary embodiments of the present invention will now be described in detail. This detailed description should not be considered as limiting the present invention, but should be understood as a more detailed description of certain aspects, features, and embodiments of the present invention.
[0026] It should be understood that the terms described in the present invention are only for describing a particular embodiment and are not intended to limit the present invention. In addition, for the numerical range in the present invention, it should be understood that each intermediate value between the upper and lower limits of the scope is also specifically disclosed. The intermediate value in any stated value or stated range, and each smaller range between any other stated value or intermediate value in the described range is also included in the present invention. The upper and lower limits of these smaller ranges can be independently included or excluded in the scope.
[0027] Unless otherwise indicated, all technical and scientific terms used herein have the same meanings as those generally understood by those skilled in the art. Although the present invention describes only preferred methods and materials, any methods and materials similar or equivalent to those described herein may also be used in the implementation or testing of the present invention. All documents mentioned in this specification are incorporated by reference to disclose and describe the methods and / or materials associated with the documents. In the event of a conflict with any incorporated document, the content of this specification shall prevail.
[0028] It will be apparent to those skilled in the art that various modifications and variations may be made to the specific embodiments of the present invention description without departing from the scope or spirit of the present invention. Other embodiments derived from the present invention description will be apparent to those skilled in the art. The present invention description and examples are exemplary only.
[0029] The words “include,” “including,” “have,” “contain,” etc. used in this document are open-ended terms, meaning including but not limited to.
[0030] Example 1 Isolation, Culture and Preservation of Lactobacillus plantarum AR1089
[0031] The fermented rice wine liquid was collected and diluted by the concentration gradient dilution method. 100 μL of the diluted liquid was spread on an MRS medium plate and cultured anaerobically at 37° C. for 40-56 hours. According to the shape, size, color and the like of the colonies, colonies with different characteristics were picked to new MRS medium plates for separation and purification by streaking to obtain isolated strains. The isolated strains were subjected to Gram staining and catalase contact tests. According to the Gram staining-positive and catalase-free characteristics of lactic acid bacteria, Gram staining-positive and catalase-negative strains were selected. DNA of the obtained strains was extracted, and the 16srDNA sequence was obtained after PCR amplification using the universal primers 27F / 1492R for the 16srDNA fragment of lactic acid bacteria. The highly homologous comparison of the strains was performed at NCBI, and the purified strain was identified as Lactobacillus plantarum AR1089.
[0032] 27F: 5'-AGAGTTTGATCCTGGCTCAG-3'; 1492R: 5'-GGTTACCTTGTTACGACTT-3'.
[0033] The above-mentioned Lactobacillus plantarum AR1089 strain was deposited at the General Microbiology Center of China Culture Collection Administration on May 17, 2023. Its deposit number is CGMCC No. 27369, and the deposit address is No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing.
[0034] Example 2 Establishment of hyperoxaluria rat model and experimental grouping
[0035] 1. Solution preparation
[0036] 0.7% sodium pentobarbital: Accurately weigh 0.14 g of sodium pentobarbital, dissolve it in 20 mL of sterile distilled water, mix well, and prepare it before use.
[0037] 0.9% saline: Weigh 9 g NaCl, add 1000 mL distilled water to fully dissolve it, and then place it in an autoclave for sterilization at 121°C for 20 min.
[0038] Preparation of Lactobacillus plantarum AR1089 suspension: centrifuge the third generation of bacterial suspension at 4°C, 6000rpm (inoculation volume per generation is 2%, growth time is 16h), discard the supernatant, resuspend in 0.9% saline, repeat the above steps 3 times until the supernatant after centrifugation is colorless and transparent. 600 The relationship between the absorbance value and CFU / mL was calculated and the bacterial concentration was adjusted using a UV-visible spectrophotometer so that the final concentration of the bacterial suspension was 10 9 CFU / mL.
[0039] 2. Animal grouping
[0040] The experimental animals were 24 6-week-old SPF Wistar rats weighing 180g±10g. After 7 days of adaptation, they were randomly divided into 3 groups: normal group, eating ordinary feed; model group, eating 3% sodium oxalate feed; treatment group, eating 3% sodium oxalate feed and gavage with Lactobacillus plantarum AR1089 suspension;
[0041] All rats were given free access to food and water. The control group and the model group were gavaged with 1 mL of normal saline every day, and the AR1089 group was gavaged with 1 mL of 10 9 CFU / mL bacterial suspension. On the 28th day, the mice were placed in metabolic cages, urine was collected for 24 hours, the urine was centrifuged at 4500rpm for 10min, the supernatant was taken, 10mL urine sample was reserved for aliquoting and stored in a -80℃ refrigerator.
[0042] After the rats were anesthetized, blood was collected from the heart. After the blood was allowed to stand for 30 minutes, it was centrifuged at 3000 rpm for 10 minutes. The serum was collected, packaged, and stored in a -80°C refrigerator.
[0043] The kidneys were removed, the arteries near the kidneys were clamped, and the kidneys on both sides were removed and weighed and recorded. The right kidney was placed in 4% paraformaldehyde for making slices. The left kidney was packaged, frozen in liquid nitrogen, and stored at -80°C.
[0044] 3. Determination indicators
[0045] 3.1 Serum indicators
[0046] (1) Serum creatinine (Cr) determination:
[0047] The Cr concentration in mouse urine was determined using a creatinine assay kit (sarcosine oxidase method). Creatinine was converted to creatine by creatinine amidohydrolase, creatine was converted to sarcosine and urea by creatine amidohydrolase, and sarcosine was converted to formaldehyde, glycine and hydrogen peroxide by sarcosine oxidase. Hydrogen peroxide was converted to purple-red compounds by 2,4-DCP and 4-aminoantipyrine by catalase. Rat serum creatinine was determined colorimetrically at a wavelength of 546 nm according to the method described in the creatinine assay kit (Nanjing Jiancheng Technology Co., Ltd.).
[0048] Use the difference between the two absorbance readings to calibrate to zero with a blank tube, and calculate △A blank and △A sample. Then calculate the creatinine content of the sample according to the formula. The result is as follows Figure 2 As shown:
[0049]
[0050] Note: △A=A2-K×A1, A1 and A2 are the absorbances read twice, K is the dilution factor.
[0051]
[0052] (2) Determination of serum urea nitrogen content:
[0053] Under heating and strong acid conditions, urea nitrogen condenses with diacetyl oxime to synthesize a red complex of biazine, and the absorbance is measured at 520 nm. The increase in absorbance is proportional to the concentration of serum urea nitrogen. Rat serum urea nitrogen was determined colorimetrically at a wavelength of 520 nm according to the method described in the urea nitrogen determination kit (Nanjing Jiancheng Technology Co., Ltd.).
[0054]
[0055] (3) Malondialdehyde (MDA) determination
[0056] The MDA content in rat serum was determined colorimetrically at a wavelength of 520 nm according to the method described in the MDA assay kit (Biyuntian Biotechnology Co., Ltd.).
[0057] like Figure 1 As shown in the results, creatinine and urea nitrogen are usually used as indicators of renal function damage. After high oxalate diet, the serum creatinine and urea nitrogen levels of rats increased significantly (P < 0.001). Lactobacillus plantarum AR1089 significantly reduced the levels of creatinine and urea nitrogen (P < 0.05) and improved renal function ( Figure 1A and B in the figure). Oxidative damage and inflammatory response caused by oxalic acid or calcium oxalate may be one of the causes of kidney stone formation. MDA reflects the degree of damage to cells after being attacked by free radicals. The higher the MDA, the more serious the cell damage. Compared with the normal group, the MDA level of rats in the model group increased significantly (P < 0.001), indicating the presence of oxidative damage. Lactobacillus plantarum AR1089 significantly reduced the MDA level (P < 0.05) and reduced the oxidative stress response in rats ( Figure 1 Middle C).
[0058] 3.2 Kidney antioxidant capacity
[0059] (1) Kidney coefficient
[0060] The kidneys of both sides of the rats were taken out and weighed, and the final weight of the rats was recorded. The rat kidney coefficient was calculated according to the formula.
[0061]
[0062] (2) Determination of renal antioxidant enzyme activity
[0063] The SOD content in the kidney was determined according to the instructions of the kit (Biyuntian Biotechnology Co., Ltd.); the CAT content in the kidney was determined according to the instructions of the kit (Nanjing Jiancheng Technology Co., Ltd.).
[0064] like Figure 2 As shown in the results, the renal tissue volume of rats fed a high-oxalate diet increased due to impaired renal function, and the renal coefficient of rats in the model group increased significantly (P < 0.001). The intervention of Lactobacillus plantarum AR1089 significantly reduced the renal coefficient of rats fed a high-oxalate diet (P < 0.05) ( Figure 2 A). The higher the SOD and CAT activities, the stronger the body's antioxidant capacity. Compared with the model group, AR1089 significantly improved the antioxidant capacity of rats fed a high oxalate diet (P < 0.05) ( Figure 2 B and C), increasing the activities of SOD and CAT antioxidant enzymes, so Lactobacillus plantarum AR1089 may alleviate hyperoxaluria by reducing oxidative stress in rats fed a high-oxalate diet.
[0065] 3.3 Urine oxalate content
[0066] Take a urine sample stored in a -80℃ refrigerator and measure the urine oxalic acid content:
[0067] At pH 2, Fe 3+It can be complexed with sulfosalicylic acid to form a purple complex, with a maximum absorption wavelength of 510nm. Oxalic acid or oxalate can make the above purple complex lighter in color, and the color of the purple complex decreases with the increase of oxalic acid in the sample. A standard curve is drawn according to the standard oxalic acid content, and the oxalic acid content in the sample is calculated by the curve equation. The oxalic acid content in rat urine is determined by the method described in the oxalic acid determination kit (Beijing Solebold Technology Co., Ltd.) by colorimetry at a wavelength of 520nm.
[0068] The results are as follows Figure 3 As shown in the figure, since about 90% of oxalic acid in the body is excreted in urine, urinary oxalic acid excretion can effectively characterize the oxalic acid level in the body and is an important indicator of hyperoxaluria. Compared with the blank group (121.9±7.58μmol / 24h), the oxalic acid concentration in the urine of the model group increased significantly to 376.2±11.57μmol / 24h (P<0.05), and AR1089 could reduce the oxalic acid level in urine by 35.38% (243.10±8.63μmol / 24h).
[0069] 3.4 Renal pathological staining analysis
[0070] (1) Kidney HE staining
[0071] After the rat kidneys were embedded, HE staining was performed on the kidneys to observe the morphology of the rat glomeruli and renal tubules.
[0072] (2) Masson staining of kidney
[0073] Masson staining can dye collagen fibers blue, and muscles, cell nuclei and red blood cells red or orange-yellow respectively. This method is of great value in observing and evaluating the fibrosis process and inflammatory response in the kidney.
[0074] (3) Assessment of renal tissue crystallization
[0075] The whole kidney of the rat was taken for Pizzolato staining. Calcium oxalate crystals were obviously black after Pizzolato staining. Ten representative Pizzolato-stained paraffin sections were prepared from each kidney tissue. The calcium oxalate crystals were quantitatively analyzed using Image J software, and the calcium oxalate crystal area ratio obtained by the software was corresponded to the above score.
[0076] The results are as follows Figure 4 As shown, Figure 4Figure A is a HE pathological section of the kidney of rats fed a high oxalate diet. By observing the structure of the glomeruli, renal tubules and renal interstitium, the normal group of rats had normal renal tissue morphology, dense renal tubules and normal glomerular structure. The renal tubules of the model group rats were significantly dilated and twisted, the tubular epithelial cells were degenerated, necrotic and even detached, and the glomeruli were damaged and atrophied. After intervention with Lactobacillus plantarum AR1089, the renal pathological damage was significantly alleviated. Figure 4 Middle B is a Masson pathological section of the kidney of rats fed a high oxalate diet. A high oxalate diet aggravates renal fibrosis, while Lactobacillus plantarum AR1089 improves renal fibrosis in rats fed a high oxalate diet (P < 0.001) ( Figure 4 (D, E). Figure 4 Middle C is a Pizzolato pathological section of the kidney of rats fed a high-oxalate diet. The high-oxalate diet caused a significant accumulation of calcium oxalate crystals in the kidneys of rats, and Lactobacillus plantarum AR1089 significantly reduced calcium oxalate deposition (P < 0.05).
[0077] 3.5 Alleviation of renal damage
[0078] The right kidney was used for immunohistochemical analysis, and the OPN and MCP-1 antibodies were purchased from Bio-Tech. The left kidney was used for total RNA extraction.
[0079] (1) Take out frozen left kidney tissue (about 0.1 g) from a -80°C freezer, dissolve it at room temperature, add 1 mL of Trizol, grind it thoroughly in a tissue grinder, leave it at room temperature for 10 min, centrifuge it at 12,000 rpm, 4°C for 10 min, slowly pipette about 600 μL of the supernatant into a new 1.5 mL EP tube, do not shake it violently, and discard the precipitate;
[0080] (2) Add 0.2 mL of chloroform, vortex for 15 seconds, mix thoroughly, and let stand for 5 minutes. Chloroform denatures the protein and accelerates the separation of the aqueous and organic phases. Centrifuge at 12,000 rpm, 4°C for 10 minutes, and carefully transfer about 300 μL of the aqueous phase to a new 1.5 mL EP tube;
[0081] (3) Add 0.6 mL of isopropanol, mix by inversion, leave at room temperature for 20 min, centrifuge at 12,000 rpm, 4°C for 10 min, remove the supernatant, and keep the precipitate;
[0082] (4) Add 1 mL of 75% ethanol to wash the precipitate, let it stand for 15 minutes until the white precipitate floats up, centrifuge at 7500 rpm, 4°C for 10 minutes, discard the supernatant, keep the precipitate, dry it at room temperature for 5-10 minutes, repeat twice. Dissolve the RNA in an appropriate amount of DEPC water and let it stand for 5-10 minutes;
[0083] (5) Determine the concentration and purity of the extracted RNA. 260 / OD280 The value should be between 1.8 and 2.2, indicating that the RNA purity is high; the integrity of the RNA is verified by agarose gel electrophoresis. The complete total RNA can be seen as three bands in the gel, with molecular weights of 28s, 18s, and 5s, and the brightness gradually decreases. RNA that meets the requirements is immediately converted into cDNA.
[0084] Real-time fluorescence quantitative PCR reaction was performed, and the specific reaction procedure was as follows: pre-denaturation at 95°C for 30 seconds; denaturation at 95°C for 5 seconds, 40 cycles; annealing at 60°C for 30 seconds. GAPDH gene was used as the internal reference gene, and the primer sequences used were as follows:
[0085] KIM-1-F: GGGTCTCCTTCACAGCACATT, KIM-1-R: CAAGGCCAGCCCTCTAATGG;
[0086] OPN-F: TGAGACTGGCAGTGGTTTGC, OPN-R: CCACTTTCACCGGGAGACA;
[0087] MCP-1-F: TGGGCCTGTTGTTCACAGTT, MCP-1-R: ACCTGCTGCTGGTGATTCTC; the results were obtained using 2 —△△Ct The gene expression level was calculated by the method.
[0088] like Figure 5 As shown, the gene expression levels of OPN, KIM-1 and MCP-1 in the kidneys of hyperoxaluric rats were significantly increased (P < 0.001). KIM-1, a type I transmembrane glycoprotein, is expressed on the epithelial cells of damaged proximal tubules, and its expression level is correlated with the severity of renal injury. OPN can participate in regulating multiple links in the formation of calcium oxalate kidney stones and can effectively regulate the deposition of calcium oxalate crystals in the kidneys in animal models. MCP-1 is a regulator of inflammatory responses that specifically regulates the aggregation and migration of inflammatory cells, especially areas where inflammatory cells invade after tissue damage. Intervention with Lactobacillus plantarum AR1089 significantly reduced the relative gene expression levels of OPN, KIM-1 and MCP-1 in rat kidneys (P < 0.05) ( Figure 5 Middle A). Immunohistochemical analysis of OPN and MCP-1 further verified that Lactobacillus plantarum AR1089 significantly reduced the expression of OPN and MCP-1 (P < 0.05) ( Figure 5 (middle B).
[0089] Example 3 Degradation of oxalic acid in spinach juice by Lactobacillus plantarum AR1089
[0090] Take 100g of fresh spinach, add 200mL of water, put it into a soymilk machine to make juice, and dispense the spinach juice into 10mL EP tubes. Pasteurize at 65℃ for 30min. Wash the activated Lactobacillus plantarum AR1089 liquid with sterile water twice and adjust the liquid concentration to 1×10 9 cfu / mL, and transferred to spinach juice at a volume percentage of 1%, and cultured at 37°C for 12 hours. The oxalic acid content in spinach was measured according to the instructions before and after fermentation (Beijing Solebow Technology Co., Ltd.).
[0091] The oxalic acid content in spinach was tested and found to be 3.19 mg / g. After fermentation with AR1089, the oxalic acid content in spinach was 2.44 mg / g and the oxalic acid degradation rate was 23.51%, thus reducing the oxalic acid content in spinach.
[0092] Example 4 Degradation of oxalic acid in spinach juice by Lactobacillus plantarum AR1089
[0093] Take 100g of fresh spinach, add 200mL of water, put it into a soymilk machine to make juice, and dispense the spinach juice into 10mL EP tubes. Pasteurize at 65℃ for 30min. Wash the activated Lactobacillus plantarum AR1089 liquid with sterile water twice and adjust the liquid concentration to 1×10 9 cfu / mL, and transferred to spinach juice at a volume percentage of 5%, and cultured at 37°C for 24 hours. The oxalic acid content in spinach was measured according to the instructions before and after fermentation (Beijing Solebow Technology Co., Ltd.).
[0094] The oxalic acid content in spinach was tested and found to be 3.29 mg / g. After fermentation with AR1089, the oxalic acid content in spinach was 1.32 mg / g, and the oxalic acid degradation rate was 59.88%, thus reducing the oxalic acid content in spinach.
[0095] Example 5 Degradation of oxalic acid in spinach juice by Lactobacillus plantarum AR1089
[0096] Take 100g of fresh spinach, add 200mL of water, put it into a soymilk machine to make juice, and dispense the spinach juice into 10mL EP tubes. Pasteurize at 65℃ for 30min. Wash the activated Lactobacillus plantarum AR1089 liquid with sterile water twice and adjust the liquid concentration to 1×10 9 cfu / mL, and transferred to spinach juice at a volume percentage of 10%, and cultured at 37°C for 36 hours. The oxalic acid content in spinach was measured according to the instructions before and after fermentation (Beijing Solebow Technology Co., Ltd.).
[0097] The oxalic acid content in spinach was tested and found to be 3.22 mg / g. After fermentation with AR1089, the oxalic acid content in spinach was 1.42 mg / g, and the oxalic acid degradation rate was 55.90%, thus reducing the oxalic acid content in spinach.
[0098] Example 6 Degradation of oxalic acid in bamboo shoots by Lactobacillus plantarum AR1089
[0099] Take 100g of fresh bamboo shoots, clean them, cut them into 2mm thick slices, put them into a 200mL glass container, add 120mL of 4% (m / v) saline, wash the activated Lactobacillus plantarum AR1089 bacterial solution twice with sterile water, and adjust the bacterial solution concentration to 1×10 9 cfu / mL, and transferred to bamboo shoots at a volume percentage of 5%, and cultured at 37°C for 24 hours. The oxalic acid content in bamboo shoots was measured according to the instructions before and after fermentation (Beijing Solebow Technology Co., Ltd.).
[0100] The oxalic acid content in bamboo shoots was tested and found to be 8.52 mg / g. After fermentation with AR1089, the oxalic acid content in bamboo shoots was 2.71 mg / g and the oxalic acid degradation rate was 68.19%, thus reducing the oxalic acid content in bamboo shoots.
[0101] In summary, the Lactobacillus plantarum AR1089 provided by the present invention intervenes in the hyperoxaluria rat model, can effectively reduce the urine oxalic acid content, promote the degradation and metabolism of oxalic acid in the body, and reduce the deposition of calcium oxalate in the kidneys; in addition, AR1089 can reduce the oxidative stress response of the kidneys and reduce the expression of OPN, KIM-1 or MCP-1 genes. The Lactobacillus plantarum AR1089 provided by the present invention can safely and effectively alleviate the kidney damage caused by high oxalic acid, and can reduce the oxalic acid content in fermented vegetables, providing an effective, safe and reliable new approach for the prevention or treatment of diseases caused by high oxalic acid.
[0102] The embodiments described above are only descriptions of the preferred modes of the present invention, and are not intended to limit the scope of the present invention. Without departing from the design spirit of the present invention, various modifications and improvements made to the technical solutions of the present invention by ordinary technicians in this field should all fall within the protection scope determined by the claims of the present invention.
Claims
1. A strain of Lactobacillus plantarum AR1089, characterized in that: The deposit number of the Lactobacillus plantarum AR1089 is CGMCC No.27369.
2. Use of Lactobacillus plantarum AR1089 as claimed in claim 1 in the preparation of a medicament for treating and / or preventing hyperoxaluria.
3. The use according to claim 2, characterized in that The Lactobacillus plantarum AR1089 plays a role in treating and / or preventing hyperoxaluria by reducing kidney oxidative stress response or reducing the expression level of OPN, KIM-1 or MCP-1 genes.
4. A vegetable fermentation agent, characterized in that: The method comprises the Lactobacillus plantarum AR1089 according to claim 1.
5. Use of the Lactobacillus plantarum AR1089 according to claim 1 or the vegetable fermentation agent according to claim 4 in reducing the oxalic acid content in vegetables.
6. The use according to claim 5, characterized in that The plant lactobacillus AR1089 is inoculated into vegetables in the form of a strain or a bacterial liquid for fermentation to reduce the oxalic acid content in the vegetables.
7. The use according to claim 6, characterized in that In terms of volume percentage, the inoculation amount of the Lactobacillus plantarum AR1089 is 1%-10%.
8. The use according to claim 7, characterized in that In terms of volume percentage, the inoculation amount of the Lactobacillus plantarum AR1089 is 5%.
9. The use according to claim 5, characterized in that The vegetables include spinach or bamboo shoots.
10. Use of the Lactobacillus plantarum AR1089 according to claim 1 or the vegetable starter culture according to claim 4 in preparing vegetable fermented food, characterized in that: The vegetables include spinach or bamboo shoots.
Citation Information
Patent Citations
Lactobacillus plantarum (L.plantarum) with capability of inhibiting kidney stone formation and application thereof
CN113308416A
Phytobacterium plantarum and method for preparing asparagus fermented beverage by using same
CN117987298A
